Annual Total Debt
$2.28 M
-$776.90 K-25.43%
31 December 2023
Summary:
ABVC BioPharma annual total debt is currently $2.28 million, with the most recent change of -$776.90 thousand (-25.43%) on 31 December 2023. During the last 3 years, it has fallen by -$833.90 thousand (-26.80%). ABVC annual total debt is now -64.86% below its all-time high of $6.48 million, reached on 31 December 2020.ABVC Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$2.33 M
-$84.80 K-3.52%
30 September 2024
Summary:
ABVC BioPharma quarterly total debt is currently $2.33 million, with the most recent change of -$84.80 thousand (-3.52%) on 30 September 2024. Over the past year, it has increased by +$48.10 thousand (+2.11%). ABVC quarterly total debt is now -64.12% below its all-time high of $6.48 million, reached on 31 December 2020.ABVC Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABVC Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +2.1% |
| 3 y3 years | -26.8% | -25.3% |
| 5 y5 years | -50.3% | -49.2% |
ABVC Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -26.8% | at low | -55.3% | +2.1% |
| 5 y | 5 years | -64.9% | at low | -64.1% | +2.1% |
| alltime | all time | -64.9% | -64.1% |
ABVC BioPharma Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.33 M(-3.5%) |
| June 2024 | - | $2.41 M(-0.0%) |
| Mar 2024 | - | $2.41 M(+5.9%) |
| Dec 2023 | $2.28 M(-25.4%) | $2.28 M(-33.1%) |
| Sept 2023 | - | $3.41 M(-34.3%) |
| June 2023 | - | $5.18 M(-0.5%) |
| Mar 2023 | - | $5.21 M(+70.5%) |
| Dec 2022 | $3.05 M(-1.8%) | $3.05 M(-1.8%) |
| Sept 2022 | - | $3.11 M(+8.4%) |
| June 2022 | - | $2.87 M(-9.6%) |
| Mar 2022 | - | $3.17 M(+2.0%) |
| Dec 2021 | $3.11 M(-52.0%) | $3.11 M(-10.6%) |
| Sept 2021 | - | $3.48 M(-44.0%) |
| June 2021 | - | $6.21 M(-0.9%) |
| Mar 2021 | - | $6.27 M(-3.3%) |
| Dec 2020 | $6.48 M(+41.6%) | $6.48 M(+47.6%) |
| Sept 2020 | - | $4.39 M(-1.4%) |
| June 2020 | - | $4.46 M(-2.8%) |
| Mar 2020 | - | $4.58 M(+0.1%) |
| Dec 2019 | $4.58 M(+472.4%) | $4.58 M(+10.7%) |
| Sept 2019 | - | $4.14 M(+15.6%) |
| June 2019 | - | $3.58 M(-4.9%) |
| Mar 2019 | - | $3.76 M(+370.1%) |
| Dec 2018 | $800.00 K(>+9900.0%) | $800.00 K(+45.5%) |
| Sept 2018 | - | $550.00 K(0.0%) |
| June 2018 | - | $550.00 K(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| Sept 2017 | $0.00(0.0%) | - |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(0.0%) |
| Sept 2016 | $0.00(0.0%) | $0.00(-100.0%) |
| June 2016 | - | $2.05 M(>+9900.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sept 2015 | $0.00(-100.0%) | $0.00(-100.0%) |
| June 2015 | - | $7000.00(0.0%) |
| Mar 2015 | - | $7000.00(0.0%) |
| Dec 2014 | - | $7000.00(0.0%) |
| Sept 2014 | $7000.00 | $7000.00(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sept 2013 | $0.00(-100.0%) | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00(-100.0%) |
| Sept 2012 | $1.12 M(-3.0%) | $1.12 M(+9.4%) |
| June 2012 | - | $1.02 M(+18.8%) |
| Mar 2012 | - | $858.50 K(-21.5%) |
| Dec 2011 | - | $1.09 M(-4.9%) |
| Sept 2011 | $1.15 M(-18.5%) | $1.15 M(0.0%) |
| June 2011 | - | $1.15 M(0.0%) |
| Mar 2011 | - | $1.15 M(-27.3%) |
| Dec 2010 | - | $1.58 M(+12.2%) |
| Sept 2010 | $1.41 M(+67.9%) | $1.41 M(+13.5%) |
| June 2010 | - | $1.24 M(+46.5%) |
| Mar 2010 | - | $848.40 K(>+9900.0%) |
| Dec 2009 | - | $200.00(-100.0%) |
| Sept 2009 | $840.20 K(-26.1%) | $840.20 K(+1.7%) |
| June 2009 | - | $825.80 K(-6.0%) |
| Mar 2009 | - | $878.80 K(-6.5%) |
| Dec 2008 | - | $940.20 K(-17.4%) |
| Sept 2008 | $1.14 M(+165.4%) | $1.14 M(-30.4%) |
| June 2008 | - | $1.63 M(+85.6%) |
| Mar 2008 | - | $880.50 K(+87.0%) |
| Dec 2007 | - | $470.80 K(>+9900.0%) |
| Sept 2007 | $428.60 K(>+9900.0%) | - |
| June 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00 |
| Dec 2003 | $4500.00 | - |
FAQ
- What is ABVC BioPharma annual total debt?
- What is the all time high annual total debt for ABVC BioPharma?
- What is ABVC BioPharma quarterly total debt?
- What is the all time high quarterly total debt for ABVC BioPharma?
- What is ABVC BioPharma quarterly total debt year-on-year change?
What is ABVC BioPharma annual total debt?
The current annual total debt of ABVC is $2.28 M
What is the all time high annual total debt for ABVC BioPharma?
ABVC BioPharma all-time high annual total debt is $6.48 M
What is ABVC BioPharma quarterly total debt?
The current quarterly total debt of ABVC is $2.33 M
What is the all time high quarterly total debt for ABVC BioPharma?
ABVC BioPharma all-time high quarterly total debt is $6.48 M
What is ABVC BioPharma quarterly total debt year-on-year change?
Over the past year, ABVC quarterly total debt has changed by +$48.10 K (+2.11%)